Press releases

All press releases Regulatory

Regulatory press release 2019-02-18

Xspray Pharma announces positive clinical data for the drug candidate HyNap-Sora

Regulatory press release 2018-12-06

Xspray Pharma has carried out a directed share issue raising gross proceeds of approximately SEK 92 million

Regulatory press release 2018-12-06

Xspray Pharma contemplates a directed share issue to continue development of its product portfolio

Regulatory press release 2018-12-04

Additional product patent in the United States for HyNap-Dasa

Regulatory press release 2018-10-25

Xspray Pharma prepares for listing on main list

Regulatory press release 2018-10-25

Notice of extraordinary general meeting in Xspray Pharma AB (publ)

Regulatory press release 2018-10-10

Xspray Pharma’s HyNap-Dasa Shows Formal Bioequivalence

Regulatory press release 2018-09-24

Ribbskottet AB increases its stake in Xspray Pharma

Regulatory press release 2018-09-09

Xspray Pharma announces positive clinical data for its lead product candidate HyNap-Dasa

Regulatory press release 2018-01-30

Xspray Pharma proposes a directed issue of 1,350,000 shares corresponding to approximately SEK 88 million to expand the product portfolio

IR contact

Kerstin Hasselgren, IRO / Senior Adviser

+46 (0)70 311 16 83

info@xspray.com

Subscribe